Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Formulated Methylene Blue for Advanced Basal Cell Carcinoma
NCT07311070Phase 3Enrolling by invitation
- Start
- Oct 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylene blue in basal cell carcinoma (BCC). Started Oct 2025; status: enrolling by invitation.
02
Drugs
methylene blue
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT07311070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07311070.